349 related articles for article (PubMed ID: 8370132)
21. Corticosteroid-induced growth hormone secretion in normal and obese subjects.
Muruais C; Cordido F; Morales MJ; Casanueva FF; Diéguez C
Clin Endocrinol (Oxf); 1991 Dec; 35(6):485-90. PubMed ID: 1769129
[TBL] [Abstract][Full Text] [Related]
22. Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects.
Cordido F; Peñalva A; Peino R; Casanueva FF; Dieguez C
Metabolism; 1995 Jun; 44(6):745-8. PubMed ID: 7783658
[TBL] [Abstract][Full Text] [Related]
23. GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.
Ross RJ; Tsagarakis S; Grossman A; Nhagafoong L; Touzel RJ; Rees LH; Besser GM
Clin Endocrinol (Oxf); 1987 Dec; 27(6):727-33. PubMed ID: 2901302
[TBL] [Abstract][Full Text] [Related]
24. Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release.
Friend K; Iranmanesh A; Login IS; Veldhuis JD
Eur J Endocrinol; 1997 Oct; 137(4):377-86. PubMed ID: 9368506
[TBL] [Abstract][Full Text] [Related]
25. Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects.
Valcavi R; Zini M
Clin Endocrinol (Oxf); 1994 Mar; 40(3):379-82. PubMed ID: 8187302
[TBL] [Abstract][Full Text] [Related]
26. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man.
Peñalva A; Carballo A; Pombo M; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1993 Jan; 76(1):168-71. PubMed ID: 8421084
[TBL] [Abstract][Full Text] [Related]
27. Sexual dimorphism of pyridostigmine potentiation of growth hormone (GH)-releasing hormone-induced GH release in humans.
Barbarino A; Corsello SM; Tofani A; Sciuto R; Della Casa S; Rota CA; Barini A
J Clin Endocrinol Metab; 1991 Jul; 73(1):75-8. PubMed ID: 2045474
[TBL] [Abstract][Full Text] [Related]
28. Effect of cholinergic tone on growth hormone-releasing hormone-induced secretion of growth hormone in normal aging.
Giusti M; Marini G; Sessarego P; Peluffo F; Valenti S; Caratti C; Giordano G
Aging (Milano); 1992 Sep; 4(3):231-7. PubMed ID: 1420407
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing's syndrome.
Leal-Cerro A; Pumar A; Villamil F; Astorga R; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1993 Apr; 38(4):399-403. PubMed ID: 8319372
[TBL] [Abstract][Full Text] [Related]
30. Role of cholinergic muscarinic pathways on the free fatty acid inhibition of GH responses to GHRH in normal men.
Peñalva A; Gaztambide S; Vazquez JA; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1990 Aug; 33(2):171-6. PubMed ID: 2225476
[TBL] [Abstract][Full Text] [Related]
31. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
Cordido F; Peñalva A; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
[TBL] [Abstract][Full Text] [Related]
32. Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II Diabetic patients.
Giustina A; Bresciani E; Tassi C; Girelli A; Valentini U
Metabolism; 1994 Jul; 43(7):893-8. PubMed ID: 8028515
[TBL] [Abstract][Full Text] [Related]
33. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression.
Cordido F; Peino R; Peñalva A; Alvarez CV; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1996 Mar; 81(3):914-8. PubMed ID: 8772550
[TBL] [Abstract][Full Text] [Related]
34. Effect of enhancement of endogenous cholinergic tone with pyridostigmine on growth hormone (GH) responses to GH-releasing hormone in patients with Cushing's syndrome.
Leal-Cerro A; Pereira JL; Garcia-Luna PP; Astorga R; Cordido F; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1990 Aug; 33(2):291-5. PubMed ID: 2225484
[TBL] [Abstract][Full Text] [Related]
35. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
36. Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation.
Giustina A; Girelli A; Alberti D; Bossoni S; Buzi F; Doga M; Schettino M; Wehrenberg WB
Clin Endocrinol (Oxf); 1991 Dec; 35(6):491-8. PubMed ID: 1769130
[TBL] [Abstract][Full Text] [Related]
37. Effect of pyridostigmine and pirenzepine on GH responses to GHRH in hyperthyroid patients.
Valcavi R; Dieguez C; Zini M; Page MD; Dotti C; Portioli I; Scanlon MF
Clin Endocrinol (Oxf); 1991 Aug; 35(2):141-4. PubMed ID: 1934529
[TBL] [Abstract][Full Text] [Related]
38. The role of the cholinergic pathway in growth hormone feedback.
Kelijman M; Frohman LA
J Clin Endocrinol Metab; 1991 May; 72(5):1081-7. PubMed ID: 1902484
[TBL] [Abstract][Full Text] [Related]
39. The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.
Hindmarsh PC; Brain CE; Robinson IC; Matthews DR; Brook CG
Clin Endocrinol (Oxf); 1991 Oct; 35(4):353-60. PubMed ID: 1684314
[TBL] [Abstract][Full Text] [Related]
40. Interaction of glucose and pyridostigmine on the secretion of growth hormone (GH) induced by GH-releasing hormone (GHRH).
Delitala G; Tomasi PA; Palermo M; Fresu P
J Endocrinol Invest; 1990 Sep; 13(8):653-6. PubMed ID: 2273206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
